MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 62 filers reported holding MEREO BIOPHARMA GROUP PLC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $191,281 | -36.3% | 591,676 | -33.6% | 0.02% | -52.1% |
| Q2 2023 | $300,235 | +50.9% | 891,676 | +44.8% | 0.05% | +33.3% |
| Q2 2022 | $199,000 | -37.4% | 615,856 | -32.8% | 0.04% | -14.3% |
| Q1 2022 | $318,000 | +3.6% | 915,856 | +7.3% | 0.04% | -8.7% |
| Q4 2021 | $307,000 | -4.7% | 853,680 | -5.5% | 0.05% | +100.0% |
| Q3 2021 | $322,000 | -6.9% | 903,680 | -4.3% | 0.02% | -17.9% |
| Q2 2021 | $346,000 | -17.4% | 944,308 | -17.6% | 0.03% | +100.0% |
| Q1 2021 | $419,000 | +0.7% | 1,146,308 | 0.0% | 0.01% | -22.2% |
| Q4 2020 | $416,000 | -39.5% | 1,146,308 | -4.2% | 0.02% | -64.0% |
| Q3 2020 | $688,000 | – | 1,196,308 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 2,048,757 | $6,904,000 | 2.75% |
| Asymmetry Capital Management, L.P. | 1,063,264 | $3,583,000 | 1.85% |
| Endurant Capital Management LP | 1,339,835 | $4,515,000 | 1.18% |
| Altium Capital Management LP | 1,250,000 | $4,213,000 | 1.17% |
| Affinity Asset Advisors, LLC | 900,000 | $3,033,000 | 1.03% |
| DAFNA Capital Management LLC | 1,249,648 | $4,211,000 | 1.00% |
| Boxer Capital, LLC | 6,226,673 | $20,984,000 | 0.71% |
| Delphi Management Partners VIII, L.L.C. | 256,734 | $865,000 | 0.60% |
| Rubric Capital Management LP | 2,914,861 | $9,823,000 | 0.57% |
| Orbimed Advisors | 17,264,763 | $58,183,000 | 0.54% |